BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21696568)

  • 1. Establishing locoregional control of malignant pleural mesothelioma using high-dose radiotherapy and (18) F-FDG PET/CT scan correlation.
    Feigen M; Lee ST; Lawford C; Churcher K; Zupan E; Scott AM; Hamilton C
    J Med Imaging Radiat Oncol; 2011 Jun; 55(3):320-32. PubMed ID: 21696568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of integrated 18-fluorodeoxyglucose position emission tomography-computed tomography in patients surveillance after multimodality therapy of malignant pleural mesothelioma.
    Tan C; Barrington S; Rankin S; Landau D; Pilling J; Spicer J; Cane P; Lang-Lazdunski L
    J Thorac Oncol; 2010 Mar; 5(3):385-8. PubMed ID: 20087231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of disease progression on 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients with malignant pleural mesothelioma undergoing multimodality therapy with pleurectomy/decortication.
    Bille A; Chicklore S; Okiror L; Cook GJ; Spicer J; Landau D; Lang-Lazdunski L
    Nucl Med Commun; 2013 Nov; 34(11):1075-83. PubMed ID: 23963351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moderately Hypofractionated Helical IMRT, FDG-PET/CT-guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs.
    Fodor A; Broggi S; Incerti E; Dell'Oca I; Fiorino C; Samanes Gajate AM; Pasetti M; Cattaneo MG; Passoni P; Gianolli L; Calandrino R; Picchio M; Di Muzio N
    Clin Lung Cancer; 2019 Jan; 20(1):e29-e38. PubMed ID: 30253920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
    Pilling J; Dartnell JA; Lang-Lazdunski L
    Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
    Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
    J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
    Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma.
    Lee TT; Everett DL; Shu HK; Jahan TM; Roach M; Speight JL; Cameron RB; Phillips TL; Chan A; Jablons DM
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1183-9. PubMed ID: 12447185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.
    Francis RJ; Byrne MJ; van der Schaaf AA; Boucek JA; Nowak AK; Phillips M; Price R; Patrikeos AP; Musk AW; Millward MJ
    J Nucl Med; 2007 Sep; 48(9):1449-58. PubMed ID: 17704250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
    Krayenbuehl J; Oertel S; Davis JB; Ciernik IF
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1593-9. PubMed ID: 17931793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.
    Rice DC; Stevens CW; Correa AM; Vaporciyan AA; Tsao A; Forster KM; Walsh GL; Swisher SG; Hofstetter WL; Mehran RJ; Roth JA; Liao Z; Smythe WR
    Ann Thorac Surg; 2007 Nov; 84(5):1685-92; discussion 1692-3. PubMed ID: 17954086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.
    Patel PR; Yoo S; Broadwater G; Marks LB; Miles EF; D'Amico TA; Harpole D; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):362-8. PubMed ID: 22516382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
    Wilcox BE; Subramaniam RM; Peller PJ; Aughenbaugh GL; Nichols Iii FC; Aubry MC; Jett JR
    Clin Lung Cancer; 2009 Jul; 10(4):244-8. PubMed ID: 19632941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
    Sharif S; Zahid I; Routledge T; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
    Miles EF; Larrier NA; Kelsey CR; Hubbs JL; Ma J; Yoo S; Marks LB
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1143-50. PubMed ID: 18262369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
    Forster KM; Smythe WR; Starkschall G; Liao Z; Takanaka T; Kelly JF; Vaporciyan A; Ahamad A; Dong L; Salehpour M; Komaki R; Stevens CW
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):606-16. PubMed ID: 12573747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma.
    Krayenbuehl J; Dimmerling P; Ciernik IF; Riesterer O
    Radiat Oncol; 2014 Jan; 9():32. PubMed ID: 24456714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for the treatment of malignant pleural mesothelioma.
    de Perrot M; Wu L; Wu M; Cho BCJ
    Lancet Oncol; 2017 Sep; 18(9):e532-e542. PubMed ID: 28884702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
    Gupta V; Krug LM; Laser B; Hudka K; Flores R; Rusch VW; Rosenzweig KE
    J Thorac Oncol; 2009 Jun; 4(6):746-50. PubMed ID: 19404212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.